Enhanc3D Genomics
Functional genomics company
Enhanc3D Genomics has raised €11M across 1 funding round from 3 investors, most recently a Series A round in Oct 2022. Based in Cambridge, UK; active in Deeptech. Data as of 4 Nov 2026.
Cambridge, UKenhanc3dgenomics.com ↗
Total raised
€11M
€11,460,267
Funding rounds
1
Investors
3
distinct backers
Active since
2022-10
latest 2022-10
Funding by year
EUR raised per yearEnhanc3D Genomics — funding by year — interactive chart.
Data table
| Enhanc3D Genomics — funding by year | |
|---|---|
| 2022 | €11M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-20 | Series A | €11M | BGF,Bioqube Ventures,Parkwalk Advisors | View deal → |
Investors
3Related news
- Enhanc3D Genomics Raises £10M in Series A Financingt.co · 2022-10
- Enhanc3D Genomics Raises £10M in Series A Financingfinsmes.com · 2022-10
Similar companies
same sector, similar size- ORCA Computing€14MUK · Deeptech
- FabricNano€11MUK · Deeptech
- Emperia€9.2MUK · Deeptech
- Caeli Nova€7.7MUK · Deeptech
- Promethean Particles€9.3MUK · Deeptech
- Gemba€17MUK · Deeptech
Global coverage: FundingData